We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,062.00
Bid: 12,018.00
Ask: 12,022.00
Change: 38.00 (0.32%)
Spread: 4.00 (0.033%)
Open: 11,950.00
High: 12,142.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Opening snapshot: Stocks sell off continues...

Mon, 15th Jun 2020 08:52

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and
Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

OPENING SNAPSHOT: STOCKS SELL OFF CONTINUES... (0745 GMT)

European shares slide on fears of second wave of coronavirus cases with Beijing reporting
new infections.

The pan-European index fell 2.5% with basic resources and travel
leading the losses down almost 4%.

In terms of single stocks, BP is down 5% after it said it will incur an up to $17.5 billion
writedown in the value of its assets.

But on a positive note, Bunzl jumped 8.5% as it forecast an increase in revenue for the
first half of the year, while shares at biopharmaceutical company Ucb jumped 10%.

(Joice Alves)

*****

ON THE RADAR: SENSIRION, EASYJET, ASTRAZENECA and M&A (0645 GMT)

The disconnect between market sentiment and corporate news flow continues with futures
pointing to a start of the week in the red for European bourses as investors fear a second wave
of infections. Meantime, some companies prepare to return to work or engage in M&A deals.

EasyJet resumes flying for the first time since March 30 with COVID-19 measures in place and
Volkswagen will begin sending workers back to plant in Mexico on Tuesday.

Swiss sensor maker Sensirion lifts 2020 outlook as sales skyrocketed on COVID-19 demand
spike for ventilator sensors, while H&M's March-May sales tumble 50%, slightly less than
expected.

AstraZeneca signed a contract with European governments to supply the region with its
potential vaccine against the coronavirus.

In the M&A world, Cineworld scraps deal to buy Cineplex; while Metro Bank is in exclusive
talks to buy peer-to-peer lender RateSetter and Italy's BPER Banca approved a revised deal with
Intesa Sanpaolo to address antitrust issues in Intesa's takeover bid for UBI Banca.

Germany says coronavirus tracing smartphone app ready to go. Deutsche Telekom and software
company SAP are involved in the project.

BP will incur an up to $17.5 billion writedown in the value of its assets after lowering its
long-term oil and gas price outlook in expectation of an accelerated transition away from fossil
fuels. The company said that the coronavirus pandemic will accelerate the pace of transition to
a lower-carbon economy.

(Joice Alves)

*****

MORNING CALL: FEARS OF SECOND WAVES (0545 GMT)

Futures are pointing to a start of the week in the red for European bourses as risk appetite
gets a hit by fears of a second wave of COVID-19 infections after Beijing recorded new
infections in recent days.

Dozens of new cases all linked to a major wholesale food market were enough to encourage
investors to seek for safe-heavens across the world as authorities in China locked down housing
districts near the market.

News flow in Europe could help to improve the mood as countries are easing border controls
and the UK opens its shops.

Global coronavirus cases have crossed 7.86 million with 430,501? deaths, according to a
Reuters tally.

(Joice Alves)

*****

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.